(SRTS) Sensus Healthcare, Inc. Marketing Mix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(SRTS) Sensus Healthcare, Inc. Complete Analysis Pack
Visual. Strategic. Downloadable.
This Sensus Healthcare, Inc. 4P's Marketing Mix Analysis explains the company’s products, pricing, distribution, and promotion in a concise, actionable format and shows how their offerings are used in clinical and aesthetic markets; this page contains a real preview/sample of the analysis so you can evaluate style and depth before buying—purchase the full version to get the complete ready-to-use report.
Product
SRT-100 photon X-ray system
SRT-100 is Sensus Healthcare, Inc.’s core low-energy superficial radiotherapy system, using 50 kV X-rays to treat non-melanoma skin cancers without surgery. It targets basal cell and squamous cell carcinomas, and also keloids and other dermatologic lesions. In Company Name’s mix, it supports a niche, office-based treatment model with low treatment burden and no incisions.
SRT-100 Vision planning platform
SRT-100 Vision planning platform adds a treatment-planning app to the SRT system, so clinicians can map care before treatment starts.
It uses embedded high-frequency ultrasound imaging to support volumetric tumor analysis, beam margin delineation, and dosimetry configuration.
That makes the SRT workflow more precise and helps Sensus Healthcare, Inc. position the product as a higher-value planning tool.
SRT-100 Plus system
The SRT-100 Plus system expands Sensus Healthcare, Inc.'s superficial radiation therapy lineup for institutional use. It sits alongside the SRT-100 and SRT-100 Vision, giving hospitals and clinics another named option in the same portfolio. In the 2025-2026 product set, this broader SRT family supports the company’s mix of recurring treatment adoption and device sales.
Sentinel service program
Sentinel service program is Sensus Healthcare, Inc. post-sale protection layer for client equipment, keeping system coverage and maintenance support in place after purchase.
It strengthens the Product offer by reducing downtime risk, supporting reliability, and adding a clear service value beyond the device sale.
- Protects equipment investment
- Extends ongoing system coverage
- Supports maintenance and uptime
Consumables and laser rentals
Sensus Healthcare’s consumables and laser rentals support repeat treatments with replacement lead shielding, disposable aprons, eye shields, ultrasound probe film, and single-use applicator tips. These items let clinicians match different lesion sizes and body areas without buying new hardware each time. In-office laser rentals also cut upfront CapEx and widen access for smaller practices.
- Repeat-use treatment support
- Single-use tips and shields
- Rental access lowers upfront cost
Sensus Healthcare’s SRT Family Expands Access to Skin Cancer Care
Sensus Healthcare, Inc. centers Product on the SRT family: SRT-100, SRT-100 Vision, and SRT-100 Plus. The core SRT-100 uses 50 kV X-rays for non-melanoma skin cancers, while Vision adds ultrasound-based planning and Plus broadens institutional use. Sentinel service and rentals lift value and lower upfront cost.
| Item | Fact |
|---|---|
| SRT-100 | 50 kV |
| Family | 3 systems |
| Service | Sentinel support |
What is included in the product
Detailed Word Document
A concise, company-specific 4P analysis of Sensus Healthcare, Inc.’s product, price, place, and promotion strategy, grounded in real market practices.
Editable Excel File
Condenses Sensus Healthcare’s 4Ps into a clear snapshot that simplifies strategy review and speeds decision-making.
Reference Sources
Provides a concise, verifiable source list linking each major Sensus Healthcare claim to industry reports, regulatory filings, and peer benchmarks for faster, defensible due diligence.
Place
Worldwide medical institution distribution
Sensus Healthcare, Inc. sells radiation therapy systems to hospitals, clinics, and specialty treatment centers, so its place is institutional, not consumer. That matters in a global market with over 100,000 hospitals worldwide, where buying decisions depend on clinical need, budgets, and regulatory approval.
Boca Raton, Florida headquarters
Sensus Healthcare, Inc. has its corporate headquarters in Boca Raton, Florida, where the company was founded in 2010. The site anchors administration, operations, and core corporate functions, so it supports day-to-day control from one central base. Boca Raton also gives Company Name access to South Florida’s business and talent pool.
Direct B2B sales channel
Sensus Healthcare, Inc. sells directly to hospitals and clinics, so its distribution is a B2B channel, not a consumer one. This fits a specialized capital-equipment model, where each sale can involve long buying cycles, clinical trials, and site-specific training.
The direct model also supports higher-touch selling for products like the SRT-100 and helps the company keep control over pricing, demos, and service. In a market where one system can cost tens of thousands of dollars, direct selling is the most practical route.
Dermatology treatment settings
Sensus Healthcare, Inc. targets dermatology clinics and specialty oncology workflows where non-melanoma skin cancer care is delivered, especially basal cell carcinoma, squamous cell carcinoma, and keloid treatment. The place strategy fits outpatient practice patterns: most skin cancer care in the U.S. is handled in office-based settings, and non-melanoma skin cancer drives over 5 million annual treatments.
- Dermatology clinics
- Specialty cancer workflows
- Basal cell carcinoma
- Squamous cell carcinoma
- Keloid care
In-office rental access
Sensus Healthcare, Inc. offers in-office laser rentals that let providers use systems without immediate ownership, lowering upfront capital needs and speeding access to treatment. This rental path fits practices that want to test demand before buying and supports shorter deployment cycles than a full sale.
It also works alongside installed-system placement, giving clinics both permanent and temporary access options. That flexibility can help preserve cash while still expanding treatment capacity.
- Lower upfront commitment
- Flexible temporary access
- Supports trial before purchase
- Complements permanent installs
Sensus Healthcare: Direct B2B Sales for High-Touch Medical Devices
Sensus Healthcare, Inc. uses a direct B2B place model: hospitals, dermatology clinics, and specialty oncology centers buy or rent systems like SRT-100. This fits a high-touch market where one system can cost tens of thousands of dollars and sales cycles are long.
| Place data | Detail |
|---|---|
| Model | Direct B2B |
| HQ | Boca Raton, Florida |
| Access | Install or rent |
Get Your Copy
Sensus Healthcare, Inc. Reference Sources
The preview shown here is the actual Sensus Healthcare, Inc. 4P's Marketing Mix analysis you’ll receive instantly after purchase—no surprises; it’s the full, editable document ready for immediate use.
Promotion
Non-surgical treatment message
Sensus Healthcare, Inc. promotes superficial radiation therapy as a non-surgical option for skin cancer and selected dermatology uses. The message stresses convenience for patients who want to avoid surgery and supports clinics with a targeted, office-based treatment path. This positions Company Name around clinical utility, speed, and lower patient burden.
Specialist medical audience
Sensus Healthcare, Inc. promotes to medical institutions and physicians, so the message is B2B and treatment-led, not consumer-led. The buy side is clinic leaders and practice decision-makers, who care most about clinical workflow, reimbursement, and patient throughput.
That audience responds to proof: peer-reviewed outcomes, procedural efficiency, and safety data tied to real cases. In 2025, Sensus Healthcare reported annual revenue of about $30 million, showing a niche business built around clinician adoption rather than mass-market promotion.
Technology differentiation
Sensus Healthcare, Inc.'s SRT-100 Vision gives promotion a clear edge: it adds ultrasound imaging, tumor analysis, and dosimetry support in one platform. That 3-in-1 setup makes the product story easy to explain and hard to copy. In 2025, the message should focus on better planning, not just treatment.
Service and support emphasis
Sensus Healthcare, Inc. uses the Sentinel program and recurring consumables to keep the customer tied to the device after the sale, so promotion can stress protection, continuity, and ongoing system support. That shifts the pitch from a one-time hardware purchase to a longer service relationship. This matters because repeat consumable use and support needs can keep revenue linked to installed systems.
- Sentinel supports post-sale retention
- Consumables drive repeat use
- Promotion should stress continuity
- Service turns sale into relationship
Portfolio breadth
Sensus Healthcare, Inc. can promote portfolio breadth by bundling devices, service, consumables, and rentals into one treatment ecosystem, which makes buying simpler for clinics. That message signals completeness and convenience; in FY2024, the model still mattered because recurring consumables and service can deepen customer ties beyond a one-time device sale.
- One vendor, full workflow
- Recurring revenue through consumables
- Service plus rentals reduce friction
Sensus Healthcare’s Niche B2B SRT Pitch Targets Clinics and Physicians
Sensus Healthcare, Inc. promotes SRT as a non-surgical skin cancer option for physicians and clinics, with messaging built around workflow, safety, and reimbursement. FY2025 revenue was about $30 million, underscoring a niche B2B sales model. The SRT-100 Vision, with ultrasound, tumor analysis, and dosimetry support, sharpens the product story.
| Promotion cue | Why it matters |
|---|---|
| Physician-led B2B selling | Targets clinic decision-makers |
| FY2025 revenue | About $30 million |
| SRT-100 Vision | 3-in-1 clinical message |
Price
Capital equipment purchase model
Sensus Healthcare, Inc. sells its main systems to institutions as medical devices, so the price model is upfront capital equipment rather than low-cost consumables. Buyers are usually hospital and clinic procurement teams, which means budget approval and ROI matter more than impulse buying.
This fits a higher-ticket, capex-led sale with longer sales cycles, demos, and service support. For Sensus Healthcare, Inc., pricing likely reflects device value, installation, and clinical workflow impact, not just unit hardware cost.
Recurring consumables pricing
Sensus Healthcare, Inc. uses recurring consumables pricing to turn each installed system into an ongoing revenue stream. After the initial sale, customers keep buying shielding, safety gear, probe film, and applicator tips, so the Company’s lifetime value per account can stay above the one-time equipment price.
Service-linked pricing
Service-linked pricing means Sentinel is sold with a paid support layer, so the customer pays for the device plus ongoing service. That lifts the total contract value and makes revenue less one-time. In FY2025, Sensus Healthcare still reported a small revenue base, so add-on service fees can matter a lot for each installed system.
Rental-based access pricing
Sensus Healthcare, Inc. can use rental-based access pricing to give clinics a lower-commitment way to offer in-office laser services, since providers pay for use instead of buying equipment upfront. That flexibility fits practices with seasonal demand, pilot programs, or uneven patient flow, and it can broaden adoption across smaller offices.
- Lower upfront cash need
- Flexible versus outright purchase
- Fits temporary or variable demand
Value-based institutional pricing
Sensus Healthcare, Inc. uses value-based institutional pricing: buyers judge cost against clinical use, workflow fit, and the treatment value of non-surgical skin care. The model is reinforced by equipment, consumables, and service, so the total spend tracks patient throughput and repeat use, not just the upfront device price.
- Links price to clinical value
- Supports workflow and throughput
- Bundles equipment, service, consumables
Sensus Healthcare’s Capex-Driven Model Hinges on ROI and Recurring Sales
Sensus Healthcare, Inc. prices on a capex model: hospitals and clinics pay upfront for systems, then add consumables and service. That makes ROI and budget approval central to the sale.
In FY2025, revenue was still a small base, so each installed system and every recurring supply order mattered more to total contract value.
The mix also supports rental-style access, which lowers entry cost for smaller practices.
| Price element | Effect |
|---|---|
| FY2025 revenue base | Small |
| Core pricing | Upfront device sale |
| Recurring price | Consumables plus service |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.